Some MS Drugs Tied to Increased Psoriasis Risk
Patients with multiple sclerosis (MS) may be more likely to develop psoriasis if they take certain B cell-depleting therapies, a
Read morePatients with multiple sclerosis (MS) may be more likely to develop psoriasis if they take certain B cell-depleting therapies, a
Read moreNEW YORK (Reuters Health) —Psoriasis patients who are new users of infliximab and adalimumab appear to be at a greater
Read morePsoriasis affects over 7.5 million adults in the United States, with prevalence nearly twice as high among Whites as non-Whites,
Read moreAtopic dermatitis (AD) is associated with lower patient satisfaction scores in adults, suggesting there are unmet needs in clinical AD
Read moreNOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NEOTIGASON® VERSION 3.0 Acitretin Consumer Medicine Information
Read more